Document Detail


Exercise-induced bronchoconstriction: elucidating the roles of leukotrienes and prostaglandins.
MedLine Citation:
PMID:  9017786     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Exercise-induced bronchoconstriction (EIB) is prevalent among patients with symptomatic asthma, especially those with moderate-to-severe airway hyperresponsiveness. This phenomenon generally manifests within the first 3-5 minutes after exercise, during which the forced expiratory volume in 1 second (FEV1) markedly decreases. Usually, the FEV1 gradually returns to baseline within an hour. Exercise should not be avoided in patients with asthma, since improved physical fitness can reduce the minute ventilation associated with a given exercise work rate and, thereby, reduce the bronchoconstrictive response. The cysteinyl leukotrienes are becoming recognized as important mediators in EIB, and prostaglandins (released at least partially as a result of leukotriene stimulation) are gaining recognition for their protective effects. Thus, pharmacologic agents that either reduce leukotriene activity or enhance prostaglandin activity, or agents that do both, may enhance prophylaxis against EIB. Currently, beta-agonists and cromolyn sodium are the mainstays of prophylactic therapy for EIB.
Authors:
P M O'Byrne
Related Documents :
7065476 - The clinical significance of volume-adjusted maximal mid-expiratory flow (iso-volume fe...
8756816 - Dissociation of bradykinin-induced plasma exudation and reactivity in the peripheral ai...
6204486 - Effects of topically applied clobetasol-17-propionate on histamine release in human skin.
7684296 - Effect of passive sensitization on the mechanical activity of human isolated bronchial ...
11536416 - Personality and exercise participation across the breast cancer experience.
23506436 - Ice slurry ingestion during cycling improves olympic distance triathlon performance in ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Pharmacotherapy     Volume:  17     ISSN:  0277-0008     ISO Abbreviation:  Pharmacotherapy     Publication Date:    1997 Jan-Feb
Date Detail:
Created Date:  1997-04-08     Completed Date:  1997-04-08     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8111305     Medline TA:  Pharmacotherapy     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  31S-38S     Citation Subset:  IM    
Affiliation:
Department of Medicine, McMaster University Health Science Center, Hamilton, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Asthma, Exercise-Induced / physiopathology*,  prevention & control
Bronchoconstriction / drug effects,  physiology*
Humans
Leukotrienes / physiology
Chemical
Reg. No./Substance:
0/Leukotrienes

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of ...
Next Document:  Use of allergen bronchoprovocation to screen drugs for anti-asthma activity.